Role of gamma-linolenic acid in counteracting doxorubicin-induced damage in cultured rat cardiomyocytes

Prostaglandins, Leukotrienes, and Essential Fatty Acids
S HreliaP Biagi

Abstract

The clinical usefulness of doxorubicin is limited by cardiotoxicity. We have demonstrated that doxorubicin has a dual negative effect on myocardial lipids, acting against highly unsaturated fatty acids (HUFAs) directly and desaturating/elongating enzymes required for their biosynthesis, thus decreasing linoleic and alpha -linolenic conversion to higher metabolites. Primary cultures of rat cardiomyocytes were challenged with different doxorubicin concentrations and doxorubicin exposure was followed by a 24-h recovery period in the absence or presence of serum, and of gamma -linolenic acid. Serum in the recovery medium did not appear to be essential for the restoration of the desaturating/elongating activities, and gamma -linolenic acid supplementation influenced only alpha -linolenic acid conversion. Serum, and particularly gamma-linolenic acid, were very important in increasing HUFA levels behind the pure biosynthesis. HUFA biosynthesis plays a role in counteracting doxorubicin toxicity, but it cannot completely overcome the depletion of these fatty acids; serum and exogenous gamma-linolenate are critical in filling the decreased HUFA pool.

References

Jul 1, 1973·Clinical Pharmacology and Therapeutics·R S BenjaminN R Bachur
Mar 1, 1970·The American Journal of Physiology·R O PeluffoR R Brenner
Jul 16, 1981·The New England Journal of Medicine·R C YoungC E Myers
Nov 2, 1995·Biochemical and Biophysical Research Communications·S HreliaP L Biagi
Aug 14, 1996·Biochemical and Biophysical Research Communications·S HreliaA Pession
Aug 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A LorenziniS Hrelia
Jan 20, 1998·Nutrition·C Galli, F Marangoni
Jul 9, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S HreliaA Bordoni

❮ Previous
Next ❯

Citations

Sep 8, 2010·The Journal of International Medical Research·L L TengH Zhang
Jul 30, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S HreliaP L Biagi
Jun 5, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Qinmei LiHongbin Si

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.